The market isn't 'deliberately' anything, it's just a market.
It is inherently unpredictable. But it would be nice to see some heavy buying into the approaching PDD results release. We haven't seen that in a while. We're at a quarter billion dollar market cap, which isn't bad for an effectively still early stage small biotech. The market has priced in some chance for success.
News 
Market Data 
Discover 
